Therapeuticsmd Stock Technical Analysis
| TXMD Stock | USD 2.36 0.06 2.48% |
As of the 14th of February 2026, TherapeuticsMD has the Coefficient Of Variation of 652.22, semi deviation of 5.03, and Risk Adjusted Performance of 0.1323. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of TherapeuticsMD, as well as the relationship between them. Please validate TherapeuticsMD variance, as well as the relationship between the maximum drawdown and semi variance to decide if TherapeuticsMD is priced more or less accurately, providing market reflects its prevalent price of 2.36 per share. Please also confirm TherapeuticsMD total risk alpha, which is currently at 0.447 to double-check the company can sustain itself at a future point.
TherapeuticsMD Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as TherapeuticsMD, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to TherapeuticsMDTherapeuticsMD | Build AI portfolio with TherapeuticsMD Stock |
Will Pharmaceuticals sector continue expanding? Could TherapeuticsMD diversify its offerings? Factors like these will boost the valuation of TherapeuticsMD. If investors know TherapeuticsMD will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every TherapeuticsMD data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
TherapeuticsMD's market price often diverges from its book value, the accounting figure shown on TherapeuticsMD's balance sheet. Smart investors calculate TherapeuticsMD's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since TherapeuticsMD's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between TherapeuticsMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if TherapeuticsMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TherapeuticsMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
TherapeuticsMD 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to TherapeuticsMD's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of TherapeuticsMD.
| 11/16/2025 |
| 02/14/2026 |
If you would invest 0.00 in TherapeuticsMD on November 16, 2025 and sell it all today you would earn a total of 0.00 from holding TherapeuticsMD or generate 0.0% return on investment in TherapeuticsMD over 90 days. TherapeuticsMD is related to or competes with ProPhase Labs, Aytu BioScience, Biofrontera, Biomx, Gelteq Limited, Ekso Bionics, and Eterna Therapeutics. TherapeuticsMD, Inc. operates as a womens healthcare company in the United States More
TherapeuticsMD Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure TherapeuticsMD's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess TherapeuticsMD upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.42 | |||
| Information Ratio | 0.1412 | |||
| Maximum Drawdown | 29.0 | |||
| Value At Risk | (7.87) | |||
| Potential Upside | 10.59 |
TherapeuticsMD Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for TherapeuticsMD's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as TherapeuticsMD's standard deviation. In reality, there are many statistical measures that can use TherapeuticsMD historical prices to predict the future TherapeuticsMD's volatility.| Risk Adjusted Performance | 0.1323 | |||
| Jensen Alpha | 0.8051 | |||
| Total Risk Alpha | 0.447 | |||
| Sortino Ratio | 0.1506 | |||
| Treynor Ratio | 0.737 |
TherapeuticsMD February 14, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1323 | |||
| Market Risk Adjusted Performance | 0.747 | |||
| Mean Deviation | 4.38 | |||
| Semi Deviation | 5.03 | |||
| Downside Deviation | 5.42 | |||
| Coefficient Of Variation | 652.22 | |||
| Standard Deviation | 5.78 | |||
| Variance | 33.42 | |||
| Information Ratio | 0.1412 | |||
| Jensen Alpha | 0.8051 | |||
| Total Risk Alpha | 0.447 | |||
| Sortino Ratio | 0.1506 | |||
| Treynor Ratio | 0.737 | |||
| Maximum Drawdown | 29.0 | |||
| Value At Risk | (7.87) | |||
| Potential Upside | 10.59 | |||
| Downside Variance | 29.41 | |||
| Semi Variance | 25.34 | |||
| Expected Short fall | (5.06) | |||
| Skewness | 0.1796 | |||
| Kurtosis | 0.4593 |
TherapeuticsMD Backtested Returns
TherapeuticsMD appears to be very risky, given 3 months investment horizon. TherapeuticsMD owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.15, which indicates the firm had a 0.15 % return per unit of risk over the last 3 months. By inspecting TherapeuticsMD's technical indicators, you can evaluate if the expected return of 0.87% is justified by implied risk. Please review TherapeuticsMD's Risk Adjusted Performance of 0.1323, semi deviation of 5.03, and Coefficient Of Variation of 652.22 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, TherapeuticsMD holds a performance score of 12. The entity has a beta of 1.19, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, TherapeuticsMD will likely underperform. Please check TherapeuticsMD's jensen alpha, semi variance, day typical price, as well as the relationship between the maximum drawdown and accumulation distribution , to make a quick decision on whether TherapeuticsMD's existing price patterns will revert.
Auto-correlation | 0.38 |
Below average predictability
TherapeuticsMD has below average predictability. Overlapping area represents the amount of predictability between TherapeuticsMD time series from 16th of November 2025 to 31st of December 2025 and 31st of December 2025 to 14th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of TherapeuticsMD price movement. The serial correlation of 0.38 indicates that just about 38.0% of current TherapeuticsMD price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.38 | |
| Spearman Rank Test | 0.38 | |
| Residual Average | 0.0 | |
| Price Variance | 0.06 |
TherapeuticsMD technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
TherapeuticsMD Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for TherapeuticsMD across different markets.
About TherapeuticsMD Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of TherapeuticsMD on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of TherapeuticsMD based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on TherapeuticsMD price pattern first instead of the macroeconomic environment surrounding TherapeuticsMD. By analyzing TherapeuticsMD's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of TherapeuticsMD's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to TherapeuticsMD specific price patterns or momentum indicators. Please read more on our technical analysis page.
TherapeuticsMD February 14, 2026 Technical Indicators
Most technical analysis of TherapeuticsMD help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for TherapeuticsMD from various momentum indicators to cycle indicators. When you analyze TherapeuticsMD charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1323 | |||
| Market Risk Adjusted Performance | 0.747 | |||
| Mean Deviation | 4.38 | |||
| Semi Deviation | 5.03 | |||
| Downside Deviation | 5.42 | |||
| Coefficient Of Variation | 652.22 | |||
| Standard Deviation | 5.78 | |||
| Variance | 33.42 | |||
| Information Ratio | 0.1412 | |||
| Jensen Alpha | 0.8051 | |||
| Total Risk Alpha | 0.447 | |||
| Sortino Ratio | 0.1506 | |||
| Treynor Ratio | 0.737 | |||
| Maximum Drawdown | 29.0 | |||
| Value At Risk | (7.87) | |||
| Potential Upside | 10.59 | |||
| Downside Variance | 29.41 | |||
| Semi Variance | 25.34 | |||
| Expected Short fall | (5.06) | |||
| Skewness | 0.1796 | |||
| Kurtosis | 0.4593 |
TherapeuticsMD February 14, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as TherapeuticsMD stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.07 | ||
| Daily Balance Of Power | (0.33) | ||
| Rate Of Daily Change | 0.98 | ||
| Day Median Price | 2.42 | ||
| Day Typical Price | 2.40 | ||
| Price Action Indicator | (0.09) | ||
| Market Facilitation Index | 0.18 |
Complementary Tools for TherapeuticsMD Stock analysis
When running TherapeuticsMD's price analysis, check to measure TherapeuticsMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TherapeuticsMD is operating at the current time. Most of TherapeuticsMD's value examination focuses on studying past and present price action to predict the probability of TherapeuticsMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TherapeuticsMD's price. Additionally, you may evaluate how the addition of TherapeuticsMD to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |